CheckMyRecalls

Brandywine Pharmaceuticals, LLC recalls Theophylline Extended-Release…

Brandywine Pharmaceuticals, LLC recalls Theophylline Extended-Release Tablets

Published
4 Nov 2026
Units affected
2 products
Agency
FDA
Country
United States

The hazard

CGMP Deviations: interruption in the ongoing stability testing program conducted at a third-party laboratory

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Theophylline Extended-Release Tablets, 100 mg, Rx Only, 100-count bottle, Distributed by: Brandywine Pharmaceuticals, LLC, West Chester, PA 19382, NDC: 71321-500-10

Theophylline Extended-Release Tablets, 200 mg, Rx Only, 100-count bottle, Distributed by: Brandywine Pharmaceuticals, LLC, West Chester, PA 19382, NDC: 71321-501-10.

Brand / company
Brandywine Pharmaceuticals, LLC
Codes / lots
Lot: 405617, Expiry: 03/31/2028 | Lot: 405620, Expiry: 03/31/2028.
Distribution
Nationwide within U.S
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 4 Nov 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.